The values in Table 1 have been recalculated from the original data to minimize copying errors in reviews, but considerable sources of error remain.
Almost always the major problem in interpreting the literature is to establish the purity of the preparations used and the degree of inactivation suffered during isolation. An attempt was made to list toxicity values obtained only from homogeneous material; except for the toxins that are so abundant in filtrates that purification is simple, this principle entailed the omission of many values obtained before modern methods of protein purification and analysis were available.
A few values (for the anthrax toxin complex, Clostridium perfringens beta-toxin, and Yersinia pestis murine toxin) are included even though the published data do not allow purities of the preparations to be estimated. These values have been placed in brackets and "<" has been used to emphasize that the figures are maximum values. Some even more suspect data have been relegated to footnotes, and a few toxins have been listed which are probably lethal but for which no data have been found. In general, although the literature frequently contains widely different estimates of toxicities, only the most lethal values are included in the table because these probably represent the purest material and the least inactivation. For toxins that require partial proteolysis for full expression of activity, values are listed only after activation.
The opposite problem of spuriously high potencies arises for proteins of limited toxicities that were isolated from the products of bacteria which produce several toxins. Staphylococci, streptococci, and clostridia are examples. Many products prepared from C. perfringens, including commercial enzymes, are contaminated with the cytolytic theta-toxin (63) .
A third source of error is the inherent inaccuracy of the determinations themselves. The number of animals used to determine toxicities is frequently insufficient for the accuracy claimed, but the offense is usually only a statistical one, for great accuracy is of no merit in these determinations. The Values are expressed per kilogram of body weight, assuming, when necessary that the mice weighed 20 g, the guinea pigs weighed 250 g, and the rabbits weighted 3 kg. Such normalization implies a linearity between dose and weight that probably holds only rarely. The assumption has been explicitly challenged for botulinum toxin by Lamanna (47) .
For all of these reasons, the values in the table must be interpreted carefully. At best they are accurate to one significant figure. (ill) Proteins with an expected 50% lethal dose for humans of 1 to 100 gLg/kg. Cloning is permitted at P1 + EK1 containment. Extrapolation to humans from the small-animal data places streptolysin 0 in this class, and it appears likely that other oxygen-labile hemolysins will belong here too, as well as many other toxins, but the data are usually not sufficient to allow decisions yet.
In addition, cloning of cholera toxin-like and ST (heat-stable)-like enterotoxins is permitted under P1 + EK1 containment, even if they should prove to be more potent than 1 ,uag/kg for humans, for the reasons discussed below.
(iv) Proteins of low toxicity. These proteins, lethal to humans at over 100 ,g/kg, are not subject to specific restrictions on cloning (except for the enterotoxins in group 3). An example is the delta-lysin of Staphylococcus aureus.
Risks Associated with Cloning Toxin Genes in
Escherichia coli These categories and the guidelines apply only to cloning in E. coli. The risk inherent in using a different host would depend on the habits of this organism. It must be emphasized that the habits of a gene's former host, including its ability to cause disease or to exchange genetic information, are no longer relevant once the gene is transplanted. For example, the knowledge that C. tetani exists in the normal bowel without pathology does not make it any safer to transfer the gene for tetanus toxin into another intestinal organism. For E. coli the major risk seems to lie in the production of a toxin in the intestine by either E. coli itself or another intestinal organism that acquired the toxin gene from E. coli. We can imagine three types of dangerous outcomes.
(i) Some of the toxin might pass out of the bowel into the general circulation and damage distant tissues. This would be most apparent for those such as tetanus and botulinum toxins, which have no effect on the bowel itself but which inactivate neural synapses. That some botulinum toxin escapes into the circulation is implicit in every case of botulism: possible mechanisms have been discussed by Bonventre (19) . Only about 1 part in 100,000 of orally administered botulinum toxin escapes (47) , but a greater proportion might escape if the toxin were to be made in the gut itself and avoid inactivation by the stomach. Wright (95, p. 420) , in reviewing a few experiments in which botulinum toxin was placed in the ileum, ileal loops, and colonic loops, concluded, "What slender evidence there is available thus suggests that most of the absorption of these toxins must take place in the stomach or in the upper portions of the small intestine." Shigella neurotoxin is substantially inactivated in the stomach (20) . The risk must be greater for adults in whom passage of proteins from the intestine is rendered more likely by such conditions as ulcers or intestinal rupture or for neonates.
(ii) Many of the toxins that are lethal when injected parenterally are cytotoxic and if pro-VOL. 46, 1982 on October 25, 2017 by guest http://mmbr.asm.org/ Downloaded from duced in the intestine will presumably cause necrosis and ulceration in the mucosa and consequently diarrhea or dysentery. The cytotoxic enterotoxin of Shigella dysenteriae is thought to act thus (41) . The mucosal damage might also be followed by a greater leakage of the toxin into the circulation, which would pose an additional risk.
(iii) The noncytotoxic enterotoxins such as cholera toxin and the heat-stable and heat-labile enterotoxins of E. coli would presumably cause secretion in the same way that they do in the natural diseases. Despite the fear historically associated with the word cholera, the dehydration consequent on the diarrhea is completely reversed by oral and intravenous administration of electrolyte solutions and, given proper care, the risk to an experimenter from a neocholera organism may be limited to discomfort.
Except for the enterotoxins, there are few data on the safe amounts of toxins in the guts of experimental animals, let alone in humans. We can only proceed on the temporary assumption that a relation exists between enteral and parenteral toxicities. We must assume that a toxin which kills when minute amounts are administered to the blood may also be a significant danger when produced in the gut, and that the more toxic it is, the greater the barriers that should be erected to restrict the toxin's production in the intestine. This may be accomplished either by imposing physical containment or by using strains of E. coli that do not colonize and have less opportunity to transfer their genetic information to abundant intestinal residents. LITERATURE CITED
